Product Information
BEXAROTENE 75 MG CAPSULE is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $5.6022 per EA under NDC 00832028500. Its NADAC has been published 56 times since Aug 21, 2024.
FDA first approved this application on Jul 25, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832028500
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/18/2024
Active Ingredients
BEXAROTENEApproval Type
Generic (ANDA)
FDA Application
ANDA209886FDA Approved
7/25/2018
TE Code
AB
On Market Since
7/25/2018
Pharmacological Classes
Price Statistics
The NADAC for BEXAROTENE 75 MG CAPSULE has been published 56 times since Aug 21, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.6022 per EA |
|---|---|
| All-time high | $5.6022 (Sep 10, 2025) |
| All-time low | $5.6022 (Aug 21, 2024) |
| 52-week high | $5.6022 |
| 52-week low | $5.6022 |
| Median price | $5.6022 |
| Average price | $5.6022 |
| Largest weekly change | 0.0% (Aug 28, 2024) |
| Weeks tracked | 56 |
| Tracking since | Aug 21, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Sep 10, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BEXAROTENE 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BEXAROTENE 75 MG CAPSULE, manufactured by Upsher-Smith Laboratories LLC, is $5.6022 per EA (NDC 00832028500), effective Sep 10, 2025.
How has the price of BEXAROTENE 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BEXAROTENE 75 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 56 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for BEXAROTENE 75 MG CAPSULE?
Since Aug 21, 2024, the NADAC for BEXAROTENE 75 MG CAPSULE has ranged from a low of $5.6022 (Aug 21, 2024) to a high of $5.6022 (Sep 10, 2025), with a median of $5.6022 per EA.
Are there cheaper alternatives to BEXAROTENE 75 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BEXAROTENE 75 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BEXAROTENE 75 MG CAPSULE?
BEXAROTENE 75 MG CAPSULE (NDC 00832028500) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.